BR9915886A - Composto, composição farmacêutica, e, método para tratar um mamìfero com uma condição relacionada com a inflamação - Google Patents

Composto, composição farmacêutica, e, método para tratar um mamìfero com uma condição relacionada com a inflamação

Info

Publication number
BR9915886A
BR9915886A BR9915886-8A BR9915886A BR9915886A BR 9915886 A BR9915886 A BR 9915886A BR 9915886 A BR9915886 A BR 9915886A BR 9915886 A BR9915886 A BR 9915886A
Authority
BR
Brazil
Prior art keywords
inflammation
treating
compound
pharmaceutical composition
related condition
Prior art date
Application number
BR9915886-8A
Other languages
English (en)
Inventor
L David Waterbury
Allan L Wilcox
John M Carney
Farah Mavandadi
Albert Danielzadeh
Original Assignee
Centaur Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centaur Pharmaceuticals Inc filed Critical Centaur Pharmaceuticals Inc
Publication of BR9915886A publication Critical patent/BR9915886A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, MéTODO PARA TRATAR UM MAMìFERO COM UMA CONDIçãO RELACIONADA COM A INFLAMAçãO" São divulgados compostos de aril nitrona 3,4,5-trisubstituídos e composições farmacêuticas contendo tais compostos. Os compostos de aril nitrona, 3,4,5-trisubstituídos têm a fórmula (I): onde R -R^ 4^ são como definidos no relatório descritivo. As composições divulgadas são utilizáveis como produtos terapêuticos para condições relacionadas com a inflamação em mamíferos, tais como artrite e como reagentes analíticos para detectar radicais livres.
BR9915886-8A 1998-12-02 1999-12-01 Composto, composição farmacêutica, e, método para tratar um mamìfero com uma condição relacionada com a inflamação BR9915886A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11054198P 1998-12-02 1998-12-02
PCT/US1999/028479 WO2000032567A1 (en) 1998-12-02 1999-12-01 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same

Publications (1)

Publication Number Publication Date
BR9915886A true BR9915886A (pt) 2001-08-21

Family

ID=22333591

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915886-8A BR9915886A (pt) 1998-12-02 1999-12-01 Composto, composição farmacêutica, e, método para tratar um mamìfero com uma condição relacionada com a inflamação

Country Status (21)

Country Link
US (1) US6342523B1 (pt)
EP (1) EP1135367A1 (pt)
JP (1) JP2002531435A (pt)
KR (1) KR20010087407A (pt)
CN (1) CN1334800A (pt)
AU (1) AU773343B2 (pt)
BR (1) BR9915886A (pt)
CA (1) CA2353402A1 (pt)
CZ (1) CZ20011830A3 (pt)
EA (1) EA004931B1 (pt)
HK (1) HK1044147A1 (pt)
HU (1) HUP0104576A3 (pt)
IL (1) IL143506A0 (pt)
IS (1) IS5958A (pt)
NO (1) NO20012727L (pt)
NZ (1) NZ512032A (pt)
PL (1) PL349916A1 (pt)
SK (1) SK7502001A3 (pt)
UA (1) UA66401C2 (pt)
WO (1) WO2000032567A1 (pt)
ZA (1) ZA200104378B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
AU2002253857A1 (en) * 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain
US20030045461A1 (en) * 2001-09-06 2003-03-06 Jen-Chang Hsia Composition and methods of esterified nitroxides gated with carboxylic acids
TW200403240A (en) * 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
TW200404069A (en) * 2002-06-28 2004-03-16 Upjohn Co Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
US7115666B2 (en) * 2002-10-15 2006-10-03 Renovis, Inc. Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
US20050059638A1 (en) * 2003-08-04 2005-03-17 Kelly Michael G. Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2005087214A1 (en) * 2004-03-09 2005-09-22 Renovis, Inc. Methods for treating multiple sclerosis and pharmaceutical compositions therefor
US8227517B2 (en) 2008-02-12 2012-07-24 Tosk, Incorporated Doxorubicin adjuvants to reduce toxicity and methods for using the same
CN101468970B (zh) 2008-04-25 2011-05-11 暨南大学 一种硝酮类化合物及其制备方法和在制药中的应用
CN102311396B (zh) * 2010-07-05 2015-01-07 暨南大学 一种吡嗪类衍生物和其制备方法及在制药中的应用
WO2013067084A1 (en) * 2011-11-01 2013-05-10 The Florida International University Board Of Trustees Silylated azulenyl nitrone spin traps as chromotropic superoxide detectors
CN104803880B (zh) * 2014-01-23 2017-11-21 广州喜鹊医药有限公司 一种具有神经保护作用的化合物及其制备方法和应用
CN109438288B (zh) * 2018-10-22 2021-05-07 河南中医药大学 一种n-硝酮取代芳香酰胺衍生物及其制备方法
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224340A (en) 1977-10-06 1980-09-23 William H. Rorer, Inc. Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds
GB2137619A (en) * 1983-03-30 1984-10-10 Gerald Scott Nitrone compounds and stabilised rubber compositions containing them
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
NZ231534A (en) 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
US5025032A (en) * 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
US5036097A (en) 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
EP0496796B1 (en) 1989-10-17 1994-08-31 Oklahoma Medical Research Foundation Method and compositions for inhibition of disorders associated with oxidative damage
US5622994A (en) 1989-10-17 1997-04-22 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5143928A (en) 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US6002001A (en) 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5270319A (en) 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5215986A (en) 1992-06-01 1993-06-01 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene oxaza heterocycles
US5840746A (en) 1993-06-24 1998-11-24 Merck Frosst Canada, Inc. Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5488145A (en) 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
ATE263559T1 (de) 1996-04-23 2004-04-15 Centaur Pharmaceuticals Inc Zubereitungen enhaltend eine nitroneverbindung für die verwendung bei der behandlung von uveitis
EP1021430A1 (en) 1996-07-19 2000-07-26 Centaur Pharmaceuticals, Inc. Furan nitrone compounds
TW429241B (en) * 1996-09-26 2001-04-11 Sumitomo Pharma Nitrone derivatives
US5994396A (en) 1997-08-18 1999-11-30 Centaur Pharmaceuticals, Inc. Furansulfonic acid derivatives and pharmaceutical compositions containing the same
MA26553A1 (fr) 1997-10-17 2004-12-20 Centaur Pharmaceuticals Inc Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69904018D1 (en) 1998-01-16 2003-01-02 Centaur Pharmaceuticals Inc Thiophennitronderivate
ZA99252B (en) 1998-01-16 1999-07-14 Centaur Pharmaceuticals Inc Thioether furan nitrone compounds.
WO1999045909A2 (en) 1998-03-13 1999-09-16 Centaur Pharmaceuticals Use of nitrone compounds for the inhibition of angiogenesis
ATE271384T1 (de) 1998-05-19 2004-08-15 Renovis Inc Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Also Published As

Publication number Publication date
KR20010087407A (ko) 2001-09-15
CA2353402A1 (en) 2000-06-08
AU773343B2 (en) 2004-05-20
EP1135367A1 (en) 2001-09-26
CN1334800A (zh) 2002-02-06
EA200100607A1 (ru) 2001-12-24
AU1929800A (en) 2000-06-19
HUP0104576A2 (hu) 2002-05-29
IS5958A (is) 2001-05-31
SK7502001A3 (en) 2002-02-05
HUP0104576A3 (en) 2002-11-28
CZ20011830A3 (cs) 2001-10-17
PL349916A1 (en) 2002-10-07
NZ512032A (en) 2004-02-27
EA004931B1 (ru) 2004-10-28
NO20012727D0 (no) 2001-06-01
WO2000032567A1 (en) 2000-06-08
UA66401C2 (en) 2004-05-17
ZA200104378B (en) 2002-08-28
US6342523B1 (en) 2002-01-29
IL143506A0 (en) 2002-04-21
NO20012727L (no) 2001-07-26
HK1044147A1 (zh) 2002-10-11
JP2002531435A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
BR9915886A (pt) Composto, composição farmacêutica, e, método para tratar um mamìfero com uma condição relacionada com a inflamação
BR9813256A (pt) Composto, composição farmacêutica, e, processos para tratar de um paciente com uma doença neurodegenerativa, para prevenir o inìcio de uma doença neurodegenerativa em um paciente, para tratar de um paciente com uma doença autoimune, para prevenir o inìcio de uma doença autoimune em um paciente, para tratar de um paciente com uma doença inflamatória e para prevenir o inìcio de uma doença inflamatória em um paciente
BR9911329A (pt) Novos pseudodipeptìdeos de acila, processo de preparação e composições farmacêuticas contendo os mesmos
DK1019368T3 (da) Acylsulfamoylbenzoesyreamider, nytteplantebeskyttelsesmidler indeholdende disse samt fremgangsmåder til deres fremstilling
ES2175837T3 (es) Talco, que contiene compuestos de plipropileno.
ES2155601T3 (es) Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
BR9911737A (pt) Composto, composição farmacêutica, métodos paraa profilaxia ou tratamento de uma condiçãohiperlipidêmica, de uma condição aterosclerótica ede hipercolesterolemia, uso de um composto eprocesso para a preparação de um composto
BR9705727A (pt) Heterocicilos com anel de cinco membros como inibidores da adesão de leucócitos e como antigonistas de vla-4.
BR0007752A (pt) Composto, processo para preparar o mesmo,método de inibir mudanças patológicas mediadaspela enzima que converte tnf-"alfa" (tace) em ummamìfero em necessidade deste, e, composiçãofarmacêutica
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
BR0016150A (pt) Compostos, composições e métodos para estìmulo de crescimento e alongamento neuronal
AR024138A1 (es) Inhibidores de la proliferacion celular
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
BR0011738A (pt) Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm
BR0108974A (pt) 3-fenil-5-alcóxi-1,3,4-oxdiazol-2-onas substituìdas e seu uso para a inibição das lipases sensìveis a hormÈnios
NO930975D0 (no) Fuktighetsherdende en-komponent polysiloksanforbindelse
ATE209187T1 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
CY1107599T1 (el) Παραγωγα του οκταϋδρο-6, 10-διοξο-6h-πυριδαζινο [1,2-α] [1,2] διαζεπινη-1-καρβοξυλικου οξεος, η διαδικασια παρασκευης τους και η εφαρμογη τους στην παρασκευη θepαπευτικα ενepγων ενωσεων
BR8300177A (pt) Compostos,processo para sua preparacao,composicoes e processo para o combate ou inibicao de uma infestacao por microorganismos em plantas de cultura
EA200000240A1 (ru) Соединения, препятствующие эффекту раннего превращения лекарственных средств
AR009809A1 (es) Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos
BRPI0400919A (pt) Composição estabilizadora, método de estabilização de uma composição, composição polimérica, e, artigo
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
BR9812875A (pt) Processos para o tratamento de artrite reumatóide em um mamìfero, e para a fabricação de uma composição terapêutica para o tratamento de artrite reumatóide em um mamìfero, uso de um composto, e, composição farmacêutica

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: RENOVIS, INC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1926 DE 04/12/2007.